ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1488

Identification of Joint Locations That Are Poor Prognostic in an Early Seropositive Erosive RA Cohort

Patrick Durez1, Sofie Robert2, Alexandra Thiry3 and Harris A Ahmad3, 1Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 2Bristol-Myers Squibb, Braine L’Alleud, Belgium, 3Bristol-Myers Squibb, Princeton, NJ

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis, Examination, prognostic factors and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients (pts) with early RA often present with multiple and different areas of joint involvement. While the ACR and EULAR guidelines specify high disease activity, erosions, seropositivity and other factors for a poor prognostic RA, limited data exist to identify which specific joints or joint locations may be indicative of disease severity and poorer prognosis.1 This analysis investigated the distribution of affected joints at baseline (BL) as well as the correlation between BL swollen joint status and disease characteristics and prognostic factors in early RA pts. Methods: Data from AGREE (NCT00122382), a double-blind Phase III study of abatacept (ABA) plus methotrexate (MTX) (n=256) vs MTX (n=253) in MTX-naïve pts who were seropositive for RF and/or ACPA with early (≤2 years [yrs]) erosive RA, were analyzed post hoc by baseline swollen joint status (present, absent) for 8 different joint locations: hands, wrists, elbows, shoulders, jaw, knees, ankles and feet. Pairwise associations of BL swollen joint status were evaluated for all evaluable joint locations. Overall characteristics and study results were previously reported.2 Results: In this early RA cohort with poor prognostic factors, (n=509), BL swelling was most frequently observed in the hands (99%), followed by the wrist (92%), ankle (79%), knee (69%), foot (66%), elbow (48%), shoulder (34%) and jaw (9%). Pts with a BL swollen knee, jaw, elbow or wrist have a poorer prognosis and more aggressive RA. When these joints were involved in this MTX-naïve, seropositive, early erosive cohort, these pts had more tender and swollen joints, higher DAS28(CRP), SDAI and CDAI than those without swelling (Table 1). Higher HAQ-DI was seen in pts with a swollen knee versus those without knee swelling (1.8 [0.6] vs 1.5 [0.7], respectively (p < 0.001)). Swollen shoulder status was significantly associated with swelling status of almost all other joint locations (elbow, foot, jaw and knee: p < 0.001), whereas swelling status of the foot and wrist were the least associated with swelling status of other joints (Table 2). Presence of BL synovitis was not associated with greater BL ACPA or RF positivity, probably due to the inclusion of mainly seropositive pts.

Conclusion: In this cohort of early, seropositive erosive RA, swelling in the knee, jaw, wrist or elbow suggest that large joint locations are associated with the poorest prognosis. Pts with such a presentation might be considered for more intensive treatment.

References: 1. Bergstra SA, et al. RMD Open 2017;3:e000568 2. Westhovens R, et al. Ann Rheum Dis 2009;68:1870–7        


Disclosure: P. Durez, BMS, Lilly, Sanofi, Pfizer, 8; S. Robert, Bristol-Myers Squibb, 3; A. Thiry, Bristol-Myers Squibb, 3,Bristol-Myers Squibb RSUs, 1; H. A. Ahmad, Bristol-Myers Squibb, 1, 3.

To cite this abstract in AMA style:

Durez P, Robert S, Thiry A, Ahmad HA. Identification of Joint Locations That Are Poor Prognostic in an Early Seropositive Erosive RA Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/identification-of-joint-locations-that-are-poor-prognostic-in-an-early-seropositive-erosive-ra-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-joint-locations-that-are-poor-prognostic-in-an-early-seropositive-erosive-ra-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology